tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Amneal Pharmaceuticals Inc

AMRX
添加自选
20.160USD
+1.450+7.75%
收盘 09-21 16:00（美东）
6.44B总市值
51.99市盈率 TTM
盘后交易 17:29 (美东)20.000USD-0.205-1.01%

Amneal Pharmaceuticals Inc

20.160
+1.450+7.75%
概览
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

AMRX 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Amneal Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值
6.44B
股息TTM
0.00
市盈率 TTM
51.99
每股收益TTM
0.39
营业收入
3.02B
净利润
-116.89M
净资产收益率
-155.38%
总资产收益率
5.25%

Amneal Pharmaceuticals Inc 财报日历

最新发布
7月 30, 2026
每股收益 / 预测值
0.18/0.22
营业收入 / 预测值
796.20M/768.21M

财务报表摘要

单季报
单季报+年报
单季报
年报
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
152.83%0.18
402.42%0.20
211.20%0.11
1608.00%0.01
268.49%0.07
113.15%0.04
75.14%-0.10
-100.80%0.00
-74.98%0.02
-553.46%-0.30
-1311.01%-0.40
--0.06
--0.08
---0.05
---0.03
---0.83
----
----
----
----
营业收入
9.89%796.20M
3.90%722.52M
11.47%814.32M
11.68%784.51M
3.24%724.51M
5.50%695.42M
18.40%730.52M
13.29%702.47M
17.15%701.78M
18.23%659.19M
1.18%616.98M
13.65%620.04M
7.10%599.05M
12.04%557.54M
13.57%609.76M
3.21%545.56M
4.54%559.36M
0.92%497.63M
5.27%536.90M
1.79%528.59M
净利润
157.22%57.66M
410.50%62.26M
212.85%35.08M
1618.59%2.37M
273.99%22.42M
113.31%12.20M
68.49%-31.08M
-101.61%-156.00K
-49.70%5.99M
-1219.93%-91.64M
-2176.69%-98.65M
460.06%9.68M
109.86%11.92M
-222.03%-6.94M
32.05%-4.33M
36.54%-2.69M
-931.32%-120.81M
-132.15%-2.16M
-109.98%-6.38M
52.79%-4.24M
利润率
77.89%8.74%
204.96%10.80%
314.40%6.09%
38.09%2.31%
105.47%4.92%
128.57%3.54%
81.23%-2.84%
-58.55%1.67%
-51.72%2.39%
-584.40%-12.39%
-1474.79%-15.13%
--4.04%
--4.96%
---1.81%
---0.96%
---15.53%
----
----
----
----
毛利率
6.34%42.01%
20.41%44.31%
1.42%36.50%
-8.99%34.92%
10.93%39.51%
1.89%36.80%
16.96%35.98%
2.32%38.37%
-3.03%35.62%
13.00%36.11%
-15.00%30.77%
--37.50%
--36.73%
--31.96%
--36.20%
--35.89%
----
----
----
----
资产负债率
-2.13%72.25%
-1.40%74.29%
-1.66%71.51%
-2.46%73.14%
-3.11%73.83%
-3.34%75.35%
-6.53%72.72%
0.47%74.98%
0.59%76.19%
1.13%77.95%
6.10%77.80%
--74.63%
--75.74%
--77.08%
--73.33%
--72.31%
----
----
----
----
利润表
营业收入
9.89%796.20M
3.90%722.52M
11.47%814.32M
11.68%784.51M
3.24%724.51M
5.50%695.42M
18.40%730.52M
13.29%702.47M
17.15%701.78M
18.23%659.19M
1.18%616.98M
13.65%620.04M
7.10%599.05M
12.04%557.54M
13.57%609.76M
3.21%545.56M
4.54%559.36M
0.92%497.63M
5.27%536.90M
1.79%528.59M
营业利润
30.33%145.98M
54.78%148.27M
46.67%114.50M
-19.85%70.37M
16.20%112.01M
12.46%95.80M
127.87%78.07M
13.75%87.80M
27.13%96.39M
130.35%85.18M
-55.36%34.26M
73.44%77.19M
34.36%75.82M
65.50%36.98M
101.10%76.75M
-22.26%44.51M
-21.75%56.43M
-54.47%22.34M
51.31%38.17M
58.25%57.25M
净利润
157.22%57.66M
410.50%62.26M
212.85%35.08M
1618.59%2.37M
273.99%22.42M
113.31%12.20M
68.49%-31.08M
-101.61%-156.00K
-49.70%5.99M
-1219.93%-91.64M
-2176.69%-98.65M
460.06%9.68M
109.86%11.92M
-222.03%-6.94M
32.05%-4.33M
36.54%-2.69M
-931.32%-120.81M
-132.15%-2.16M
-109.98%-6.38M
52.79%-4.24M
资产负债表
流动资产
22.86%1.95B
19.03%1.80B
20.37%1.91B
21.49%1.84B
6.68%1.58B
9.45%1.51B
15.24%1.59B
3.93%1.51B
4.48%1.49B
5.56%1.38B
-2.41%1.38B
2.55%1.46B
-8.48%1.42B
-5.93%1.31B
-7.12%1.41B
-9.58%1.42B
-0.63%1.55B
-10.90%1.39B
-2.03%1.52B
1.72%1.57B
流动负债总额
-20.23%883.19M
-32.33%728.05M
-21.96%881.63M
-21.28%862.11M
-0.65%1.11B
28.94%1.08B
33.45%1.13B
43.99%1.10B
43.35%1.11B
18.57%834.39M
12.46%846.60M
-7.02%760.60M
-21.72%777.35M
16.89%703.71M
11.16%752.80M
22.58%818.00M
47.59%993.06M
-5.45%602.04M
0.05%677.24M
-0.08%667.34M
总资产
10.33%3.78B
5.20%3.54B
5.05%3.68B
4.01%3.60B
-2.48%3.42B
-2.64%3.37B
0.83%3.50B
-6.13%3.46B
-5.16%3.51B
-4.69%3.46B
-8.60%3.47B
-4.83%3.69B
-8.43%3.70B
-6.75%3.63B
-3.56%3.80B
-2.53%3.87B
0.46%4.04B
-1.80%3.89B
-1.66%3.94B
-1.56%3.97B
总负债
5.88%3.74B
4.72%3.59B
3.84%3.75B
4.37%3.71B
-0.90%3.54B
-2.71%3.42B
4.59%3.61B
0.61%3.55B
0.49%3.57B
0.80%3.52B
-4.50%3.45B
-3.99%3.53B
-8.23%3.55B
0.30%3.49B
1.19%3.62B
2.46%3.68B
6.49%3.87B
-3.11%3.48B
-2.41%3.57B
-2.66%3.59B
总权益
129.35%33.02M
22.60%-45.97M
34.87%-71.33M
-17.51%-109.95M
-95.75%-112.53M
6.66%-59.39M
-647.26%-109.51M
-160.66%-93.57M
-138.13%-57.49M
-147.25%-63.63M
-89.12%20.01M
-20.62%154.24M
-12.85%150.77M
-66.95%134.67M
-49.87%183.98M
-49.29%194.29M
-55.67%172.99M
11.10%407.41M
6.39%366.97M
10.04%383.17M
现金流量表
经营净额
-125.35%-21.24M
-461.00%-26.74M
10.36%130.31M
-16.45%118.45M
111.36%83.82M
267.98%7.41M
-13.06%118.08M
74.20%141.77M
449.55%39.66M
-103.16%-4.41M
683.13%135.82M
-13.02%81.39M
90.96%-11.35M
16.09%139.71M
-136.82%-23.29M
13.61%93.57M
-141.70%-125.52M
-18.76%120.34M
-40.30%63.26M
83.95%82.36M
投资净额
-362.36%-122.74M
-21.98%-21.71M
-183.04%-45.45M
-8.46%-22.46M
-310.63%-26.55M
9.93%-17.80M
49.33%-16.06M
-53.70%-20.71M
47.37%-6.46M
-68.36%-19.76M
-176.40%-31.69M
72.68%-13.48M
23.78%-12.28M
87.95%-11.74M
86.82%-11.47M
-324.07%-49.33M
80.56%-16.12M
-667.31%-97.39M
-173.53%-86.97M
21.30%-11.63M
融资净额
290.37%79.36M
-50.78%-59.05M
83.47%-10.12M
164.37%59.44M
-18.81%-41.69M
-69.15%-39.17M
39.30%-61.20M
-6.65%-92.35M
-186.28%-35.09M
-79.50%-23.16M
-354.87%-100.83M
-87.69%-86.58M
-152.72%-12.26M
79.05%-12.90M
26.96%-22.17M
-5.92%-46.13M
161.07%23.25M
-135.46%-61.57M
-169.01%-30.35M
-194.13%-43.55M

营业收入

业务

报告期:
暂无数据

地区

报告期:
暂无数据

常见问题

Amneal Pharmaceuticals Inc的总收入是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，总收入达到了3.02B（同比变化2.79B）。

Amneal Pharmaceuticals Inc的流动资产是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，流动资产为1.91B（同比变化20.37）。

Amneal Pharmaceuticals Inc的总资产是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，Amneal Pharmaceuticals Inc的总资产为3.68B（同比变化5.05）。

Amneal Pharmaceuticals Inc的总负债是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，Amneal Pharmaceuticals Inc的总负债为3.75B（同比变化3.84）。

Amneal Pharmaceuticals Inc的总权益是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，Amneal Pharmaceuticals Inc的总权益为-71.33M（同比变化34.87）。

Amneal Pharmaceuticals Inc的净营业收入是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，Amneal Pharmaceuticals Inc的净营业收入为397.91M（同比变化14.53）。

Amneal Pharmaceuticals Inc的净投资是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，Amneal Pharmaceuticals Inc的净投资为-112.26M（同比变化-78.21）。

Amneal Pharmaceuticals Inc的净融资是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，Amneal Pharmaceuticals Inc的净融资为-31.53M（同比变化85.11）。

Amneal Pharmaceuticals Inc的每股收益（EPS）是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，每股收益（EPS）为0.23（同比变化160.78）。

Amneal Pharmaceuticals Inc的净利润是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，净利润为72.06M（同比变化161.65）。

Amneal Pharmaceuticals Inc的净利润率是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，净利润率为4.24（同比变化260.28）。

Amneal Pharmaceuticals Inc的毛利率是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，毛利率为36.88（同比变化0.98）。

Amneal Pharmaceuticals Inc的债务与资产比率是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，债务与资产比率为71.51（同比变化-1.66）。

Amneal Pharmaceuticals Inc的资产回报率（ROA）是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，资产回报率（ROA）为3.56（同比变化268.21）。

Amneal Pharmaceuticals Inc的营业利润是多少？

根据Amneal Pharmaceuticals Inc的FY2025财报，营业利润为397.91M（同比变化14.53）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策